| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56abb7a905b2aba4c53d3d3debee8c14 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-04 |
| filingDate |
1994-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbccf32c5235e5131cc855a7105cf1b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cef8e428c8d477d23331552da011e84d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f05b8e83998147aa3a5f47f694e4caa |
| publicationDate |
1995-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H07165704-A |
| titleOfInvention |
13,14-Dihydro-15-keto-16-desbutyl-16-trifluoromethylphenoxy-prostaglandin E2 |
| abstract |
(57) [Summary] [Objective] To provide a novel prostaglandin compound having uterine contractile activity. A free form, an O-protected form, a physiologically acceptable salt form, or a physiologically acceptable and physiologically hydrolysable ester form of 13,14-dihydro-15-keto- 16-desbutyl-16-trifluoromethylphenoxy-prostaglandin E 2 and a uterine contractile agent containing the compound as an active ingredient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011513414-A |
| priorityDate |
1988-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |